Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Basolateral amygdala neuropeptide Y system modulates binge ethanol consumption
    Published on 2023-09-27
    2 years ago
  • Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex
    Published on 2023-09-26
    2 years ago
  • Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala
    Published on 2023-09-26
    2 years ago
  • C-reactive protein moderates associations between racial discrimination and ventromedial prefrontal cortex activation during attention to threat in Black American women
    Published on 2023-09-26
    2 years ago
  • In memoriam: Eugene S Paykel, MD, FRCP, FRCPsych, FMedSci
    Published on 2023-09-23
    2 years ago
  • Cognition-enhancing and cognition-impairing doses of psychostimulants exert opposing actions on frontostriatal neural coding of delay in working memory
    Published on 2023-09-23
    2 years ago
  • Transdiagnostic subgroups of cognitive impairment in early affective and psychotic illness
    Published on 2023-09-22
    2 years ago
« Previous 1 … 60 61 62 63 64 … 143 Next »
Journal of Psychopharmacology
  • Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes
    Published on 2022-01-05
    4 years ago
  • Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
    Published on 2022-01-05
    4 years ago
  • MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults
    Published on 2022-01-05
    4 years ago
  • The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation
    Published on 2022-01-04
    4 years ago
  • Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia
    Published on 2022-01-04
    4 years ago
  • Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction
    Published on 2022-01-04
    4 years ago
  • Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans
    Published on 2021-12-31
    4 years ago
« Previous 1 … 60 61 62 63 64 … 124 Next »
European Neuropsychopharmacology
  • The potential of TAAR1 agonists in bipolar disorder
    Published on 2022-07-06
    3 years ago
  • The antipsychotic paradox: Lessons regarding determinants of premature mortality
    Published on 2022-07-03
    3 years ago
  • Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors: Glutathione in COVID-19
    Published on 2022-06-29
    3 years ago
  • Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery
    Published on 2022-06-26
    3 years ago
  • Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder
    Published on 2022-06-26
    3 years ago
  • Peripheral versus central nervous system cytokine levels in bipolar disorder: Do they converge on the same pathophysiological processes?
    Published on 2022-06-25
    3 years ago
  • The importance of evidence synthesis in psychopharmacology: Insights from a scientometric approach
    Published on 2022-06-25
    3 years ago
« Previous 1 … 60 61 62 63 64 … 145 Next »

   Pharma Pub